DREAM / The Prime Minister resigns and wakes up under the Parisian bridge!

 Kliko këtu për të tjera
Voxpress:

This common drug may reduce cancer risk

2026-04-24 21:06:18Lifestyle SHKRUAR NGA REDAKSIA VOX
This common drug may reduce cancer risk
Scientists are understanding the biological mechanisms that drive and role of aspirin in preventing tumors.

Aspirin, the four-thousand-year-old medicine, which is known worldwide as a simple tool to treat pain and fever, is proving to be one of the most promising discoveries in modern oncology.

This ancient medicine has shown an extraordinary ability to prevent the formation and spread of several types of tumors, findings that are fundamentally changing global health policies.

The case of Nick James, who carries Lynch Syndrome, shows the power of this treatment. After a decade of regular aspirin use, he remains cancer-free, despite a high genetic predisposition.

Lynch syndrome increases the risk of bowel cancer by up to 80 percent, but studies led by professors like John Burn have proven that a low daily dose can halve this risk.

The history of aspirin begins with clay tablets in Mesopotamia and the use of willow bark by the ancient Egyptians and Greeks, who unknowingly used salicin to calm the body.

Only in the 19th century did scientists manage to synthesize acetylsalicylic acid, making it less irritating to the stomach and more accessible to ordinary people.

For decades, aspirin was recommended primarily for blood thinning and cardiovascular protection, but as early as 1972, research on mice suggested that it could stop metastasis.

Today, science is finding increasingly strong evidence in humans. In Sweden, recent research from 2025 showed that patients who had undergone colorectal cancer and took aspirin after surgery were much less likely to have the disease return.

However, the big question remains how this process works at the molecular level. Aspirin acts both inside and outside the cell, inhibiting the enzyme Cox-2, which activates signaling pathways for uncontrolled cell growth.

A surprising new discovery suggests that aspirin can make cancer "visible" to the immune system. By blocking thromboxane A2, a clotting factor, aspirin prevents cancer cells from being hidden from protective T cells.

This means our immune system can identify and destroy them more effectively before tumors form. This discovery is particularly important for stopping the process of metastasis, where malignant cells travel through the blood to invade other organs.

But despite these impressive results, doctors are urging caution. Aspirin is not a universal cure-all without risks. If taken without consulting a doctor, it can cause internal bleeding, ulcers, and hemorrhage.

There is also ongoing debate about whether everyone over the age of fifty should take it as a preventative measure. But most experts recommend that its use be limited to high-risk groups.


Në përputhje me standarded JTI

Video

SHIKO KANALIN NE YOUTUBE
×